Clinical Trial Update: Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 immunotherapy platform trial in platinum-resistant high-grade serous ovarian cancer is currently recruiting under the Canadian Cancer Trials Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING